'''5F-PB-22''' ('''5F-QUPIC''' or '''Quinolin-8-yl 1-pentyfluoro-1''H''-indole-3-8-carboxylate''') is a [[designer drug]] which acts as a [[cannabinoid agonist]].<ref>{{Cite journal | doi = 10.1021/acschemneuro.5b00107| title = Effects of Bioisosteric Fluorine in Synthetic Cannabinoid Designer Drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135| journal = ACS Chemical Neuroscience| volume = 6| issue = 8| pages = 150508124201002| year = 2015| last1 = Banister | first1 = S. D. | last2 = Stuart | first2 = J. | last3 = Kevin | first3 = R. C. | last4 = Edington | first4 = A. | last5 = Longworth | first5 = M. | last6 = Wilkinson | first6 = S. M. | last7 = Beinat | first7 = C. | last8 = Buchanan | first8 = A. S. | last9 = Hibbs | first9 = D. E. | last10 = Glass | first10 = M. | last11 = Connor | first11 = M. | last12 = McGregor | first12 = I. S. | last13 = Kassiou | first13 = M. | pmid=25921407}}</ref> The structure of 5F-PB-22 appears to have been designed with an understanding of [[structure-activity relationship]]s within the indole class of cannabinoids.<ref>{{cite web | url=http://forendex.southernforensic.org/index.php/detail/index/1233 | title=5F-PB-22 | publisher=Forendex | accessdate=24 June 2015}}</ref>
